Biotech with exciting gene therapy climbs 50% in a week – The Pharma Letter (registration)
The Pharma Letter (registration) |
Biotech with exciting gene therapy climbs 50% in a week
The Pharma Letter (registration) US gene therapy developer Abeona Therapeutics (Nasdaq: ABEO) is set to start trading on Monday with a share price worth around $13.60, more than 50% higher than it was a week ago. It comes amid excitement at the potential of Abeona's EB-101 gene … |
